The Role of New Prognostic Markers and Comorbidities on the Outcome of Patients with Chronic Lymphocytic Leukemia in a Malaysian Referral Centre

Dr. Lee Bee Sun; Dr. Tan Sen Mui; Ms Phan Chin Lee; Prof Dr. Cheong Soon Keong; Dato Dr. Chang Kian Meng

Authors

Dr. Lee Bee Sun
Dr. Tan Sen Mui
Ms Phan Chin Lee
Prof Dr. Cheong Soon Keong
Dato Dr. Chang Kian Meng

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

The Role of New Prognostic Markers and Comorbidities on the Outcome of Patients with Chronic Lymphocytic Leukemia in a Malaysian Referral Centre. (2019). Global Journal of Medical Research, 19(F1), 13-22. https://medicalresearchjournal.org/index.php/GJMR/article/view/1678

Download Citation

References

C Rozman, E Montserrat (1995) Chronic lymphocytic leukemia. 333, 1052-1057.

J R Anderson, J O Armitage, D Weisenburger (1998) Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic.locations. Non-Hodgkin's Lymphoma Classification Project. 717-720.

K Rai, A Sawitsky, E Cronkite, A Chanana, R N Levy, B Pasternack (1975) Clinical staging of chronic lymphocytic leukemia. 46(2), 219-234.

J Binet, M Lepoprier, G Dighiero (1977) A clinical staging system for chronic lymphocytic leukemia: prognostic significance. 40, 855-864.

C Nicholas (2012) Implications of new prognostic markers in chronic lymphocytic leukemia. 76-87.

Natali Pflug, Jasmin Bahlo, Tait Shanafelt, Barbara Eichhorst, Manuela Bergmann, Thomas Elter, Kathrin Bauer, Gebhart Malchau, Kari Rabe, Stephan Stilgenbauer, Hartmut Döhner, Ulrich Jäger, Michael Eckart, Georg Hopfinger, Raymonde Busch, Anna-Maria Fink, Clemens-Martin Wendtner, Kirsten Fischer, Neil Kay, Michael Hallek (2014) Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. 124(1), 49-62.

R Richard (2010) Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia.

L Rassenti, S Jain, M J Keating (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. 112(5), 1923-1930.

Carolina Reyes, Sacha Satram-Hoang, Khang Hoang, Faiyaz Momin, Sridhar Guduru, Sandra Skettino (2012) What Is the Impact of Comorbidity Burden On Treatment Patterns and Outcomes in Elderly Chronic Lymphocytic Leukemia Patients?. 120(21), 758-758.

M Hallek, B Cheson, D Catovsky (2008) Hallek et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446-5456.. 112(13), 5259-5259.

Stefano Molica (2006) Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. 47(8), 1477-1480.

L Morton, S S Wang, S Devesa (2006) Lymphoma incidence patterns by WHO subtype in the united states, 1992-2001. 107, 265-276.

Louise Watson, Peter Wyld, Daniel Catovsky (2008) Disease burden of chronic lymphocytic leukaemia within the European Union. 81(4), 253-258.

E Montserrat (2006) New Prognostic Markers in CLL. 279-284.

H Döhner, K Fischer, M Bentz (1995) p53 gene deletion predicts for poor survival and nonresponse to therapy with purine analogs in chronic B-cell leukemias. 85, 1580-1589.

Michael Grever, David Lucas, Gordon Dewald, Donna Neuberg, John Reed, Shinichi Kitada, Ian Flinn, Martin Tallman, Frederick Appelbaum, Richard Larson, Elisabeth Paietta, Diane Jelinek, John Gribben, John Byrd (2007) Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997. 25(7), 799-804.

T J Hamblin, J Orchard, A Gardiner, D Oscier, Z Davis, F Stevenson (2000) Immunoglobulin V genes and CD38 expression in CLL. 95(7), 2455-2457.

Z Matrai, K Lin, M Dennis (2001) CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. 97, 1902-1903.

Rajendra Damle, Tarun Wasil, Franco Fais, Fabio Ghiotto, Angelo Valetto, Steven Allen, Aby Buchbinder, Daniel Budman, Klaus Dittmar, Jonathan Kolitz, Stuart Lichtman, Philip Schulman, Vincent Vinciguerra, Kanti Rai, Manlio Ferrarini, Nicholas Chiorazzi (1999) Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia. 94(6), 1840-1847.

Paul Thurmes, Timothy Call, Susan Slager, Clive Zent, Gregory Jenkins, Susan Schwager, Deborah Bowen, Neil Kay, Tait Shanafelt (2008) Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. 49(1), 49-56.

Jay Piccirillo, R M Tierney, I Costas, L Grove, E L Spitznagel, Jr (2004) Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry. 291(20), 2441.

P Thurmes, T Call, S Slager, C Zent, G Jenkins, S Schwager (2008) Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. 49(1), 49-56.